Table 2.
MRI characteristics of study population
| T2DM (n = 27) | T2DM-HT (n = 23) | Control (n = 31) | P value | |
|---|---|---|---|---|
| LVEDV index (mL/m2) | 59.8 ± 15.3 | 62.5 ± 8.5 | 64.1 ± 11.1 | 0.404 |
| LVESV index (mL/m2) | 27.5 ± 5.7 | 29.1 ± 7.8 | 27.7 ± 6.3 | 0.681 |
| SV | 34.5 ± 6.2 | 33.4 ± 2.9 | 36.4 ± 6.0 | 0.131 |
| LVEF (%) | 56.2 ± 5.3 | 58.8 ± 4.5 | 57.2 ± 4.2 | 0.143 |
| LVM index (g/m2) | 56.6 ± 8.6 | 57.9 ± 5.5 | 55.5 ± 6.4 | 0.473 |
| LAV index (mL/m2) | 37.9 ± 7.8 | 36.4 ± 10.1 | 37.1 ± 11.1 | 0.866 |
| LVGRS (%) | 87.9 ± 27.6 | 80.4 ± 32.2 | 78.7 ± 18.6 | 0.382 |
| LVGCS (%) | −21.2 ± 4.4 | −20.1 ± 3.9 | −21.4 ± 2.6 | 0.364 |
| LVGLS (%) | −22.5 ± 3.6 | −22.0 ± 4.5 | − 21.9 ± 2.7 | 0.815 |
| LAGRS (%) | −29.2 ± 4.7*# | −34.8 ± 7.3 | −32.9 ± 3.9 | 0.001 |
| LAGCS (%) | 27.6 ± 3.6*# | 39.4 ± 12.7$ | 33.9 ± 8.7 | <0.001 |
| LAGLS (%) | 23.8 ± 5.5*# | 33.5 ± 6.7 | 30.9 ± 6.0 | <0.001 |
| RVGLS (%) | −22.0 ± 3.4# | −21.1 ± 5.5$ | −26.0 ± 7.4 | 0.005 |
* significant difference between T2DM patients and T2DM-HT patients, p<0.05; # significant difference between T2DM patients and control groups, p<0.05; $ significant difference between T2DM-HT patients and control groups, p<0.05
T2DM-HT, type 2 diabetes mellitus with hypertension; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; SV: stroke volume; LVEF, left ventricular ejection fraction; LVM, left ventricular mass; LAV, left atrial volume; LVGRS, left ventricular global radial strain; LVGCS, left ventricular global circumferential strain; LVGLS, left ventricular